New medicines aren’t always available through public drug plans when Canadian patients need them. After Health Canada approves a new medicine as safe and effective, Canadians still wait an average of two years for access. These delays have existed for many years, yet little progress was made in 2025, with the notable exception of the Ontario government’s Funding Accelerated for Specific Treatments (FAST) Program.
